tiprankstipranks
TipRanksTop Financial ExpertsInsidersClay Siegall

Clay Siegall Insider Profile

60 Followers
Clay Siegall, President & CEO, Director at Immunome, holds 870.70K shares in Immunome (Ticker: IMNM), holds ― shares in Tourmaline Bio (Ticker: TRML), holds 318.61K shares in Shattuck Labs (Ticker: STTK).
See the Hottest Stocks Based on Insider Trading >
tipranks
Clay Siegall

Clay Siegall
Immunome (IMNM)
President & CEO, Director

Ranked #2,793 out of 108,328 Corporate Insiders

Profitable Transactions

78%
14 out of 18 Profitable Transactions

Average Return

+31.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$22M
89.54%
10.18%
0.29%
0.00%
0.00% Others
A breakdown of Clay Siegall's holdings
See the Top Stocks by Insiders

Insider Roles

Immunome
(IMNM)
President & CEO, Director
Shattuck Labs
(STTK)
Director
Ultragenyx Pharmaceutical
(RARE)
Director
Synlogic
(SYBX)
Director
+1 other positions
Roles that Clay Siegall holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Immunome
(IMNM)
Rating:Informative Buy
Date:Mar 26, 2025 - Mar 26, 2026
Return:+187.80%
The most profitable trade made by Clay Siegall
See the Latest Stocks Traded by Insiders

Clay Siegall's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IMNM
Immunome
Jul 27, 2026
President & CEO, Director
Uninformative Buy
―
$19.82M
TRML
Tourmaline Bio
―
―
―
―
STTK
Shattuck Labs
Jun 11, 2026
Director
Informative Buy
250.00K
$2.25M
SGEN
Seagen
Apr 22, 2022
―
Uninformative Sell
272.02K
$152.35M
SYBX
Synlogic
―
Director
―
―
NRIX
Nurix Therapeutics
―
Director
―
―
ALDR
Alder Biopharmaceuticals
Oct 24, 2019
―
Uninformative Sell
570.85K
$0.00
RARE
Ultragenyx Pharmaceutical
Aug 11, 2020
Director
Uninformative Buy
670.27K
$63.52K
List of latest transactions for each holding click on a transaction to see Clay Siegall's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Clay Siegall insider profile FAQ

What is the percentage of profitable transactions made by Clay Siegall?
The percentage of profitable transactions made by Clay Siegall is 78%.
    What is the average return per transaction made by Clay Siegall?
    The average return per transaction made by Clay Siegall is 31.20%.
      What stocks does Clay Siegall hold?
      Clay Siegall holds: IMNM, TRML, STTK, SGEN, SYBX, NRIX, ALDR, RARE stocks.
        What was Clay Siegall’s latest transaction?
        Clay Siegall latest transaction was an Uninformative Buy of ―.
          What was Clay Siegall's most profitable transaction?
          Clay Siegall’s most profitable transaction was an Informative Buy of IMNM stock on March 26, 2025. The return on the trade was 187.80%.
            What is Clay Siegall's role in Immunome?
            Clay Siegall's role in Immunome is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.